SecBot SecBot
Insider Cluster (2 insiders) ·Filed May 28, 2026

NBIX

NEUROCRINE BIOSCIENCES INC
NEUTRAL
Impact 4/10
Horizonweeks Processed5mo ago
Insider cluster: 2 insiders, $38.4M total
Actionable Insight • Neutral

The sales are routine in size relative to market cap and follow a major acquisition close, likely driven by post-deal portfolio rebalancing rather than fundamental concern. Monitor for any additional insider sales in the next 30 days; a sustained pattern would warrant closer attention. The acquisition integration and debt service remain the key catalysts.

DirectionNeutral
Confidencemedium
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$157.77
T+0 close · May 28, 2026 · via day close
Latest settled
−3.35%
T+60 · $152.49
Vs SPY
−4.27%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 29 $157.77entry
  2. T+1 · 6mo ago +1.72%α +1.46% · $160.48
  3. T+5 · 6mo ago +3.49%α +6.01% · $163.27
  4. T+20 · 5mo ago +6.82%α +10.45% · $168.52
  5. T+60 · 3mo ago −3.35%α −4.27% · $152.49

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two Neurocrine insiders sold a combined $38.43M in shares over the past week, with Director Kevin Gorman accounting for $37.82M (245.1K shares at $154.33) and the Chief Corporate Affairs Officer selling $609K. The sales follow the May 18 closing of the $2.9B Soleno Therapeutics acquisition, which added $600M in new debt. At 0.24% of market cap ($15.7B), the total sell value is modest and likely reflects portfolio rebalancing or tax planning post-deal, not a bearish signal on the business.

Key Financial Metrics

Direction
selling
Total Value
$38.4M
Insiders
2

Key Facts

  • Director Kevin Gorman sold 245,100 shares for $37.82M on May 19, 2026.
  • Chief Corp. Affairs Officer David Boyer sold 3,888 shares for $609K on May 26, 2026.
  • Total insider sales of $38.43M represent ~0.24% of NBIX's $15.7B market cap.
  • Sales occurred within 10 days of closing the $2.9B Soleno Therapeutics acquisition, funded in part with $600M in new debt.
  • No open-market purchases were reported in the cluster.

Financial Impact

Insider sales of $38.43M, or 0.24% of market cap, below the 0.5% materiality threshold.

dilutioninsider_sales

Risk Factors

  • Post-acquisition integration risk for Soleno's VYKAT XR could pressure near-term earnings.
  • Additional $600M in debt increases leverage, though the revolving credit facility provides flexibility.
  • Further insider selling without purchases could signal waning confidence.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
86% bullish (35 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-NBIX-1780006230820

Track record

30 reports on NBIX

Performance horizon

3 of 4 bullish or bearish reports moved the stock their way by T+20. Best: +27.40% at T+60 after the Apr 6, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 10, 20266d ago 144 Neutral 2/10 Entry $174.41 Now $165.31 −5.22% settles Dec 10
  2. Nov 10, 20267d ago PTAB Trial Neutral 3/10 Entry $169.14 Now $165.31 −2.26% settles Dec 9
  3. Nov 10, 20267d ago PTAB Trial Neutral 3/10 Entry $169.14 Now $165.31 −2.26% settles Dec 9
  4. Nov 10, 20267d ago PTAB Trial Neutral 3/10 Entry $169.14 Now $165.31 −2.26% settles Dec 9
  5. Nov 2, 202614d ago Press Release Bullish 6/10 No price data
  6. Nov 2, 202614d ago 144 Neutral 2/10 Entry $164.85 Now $165.31 +0.28% settles Dec 2
  7. Nov 2, 202614d ago 8-K Bullish 6/10 Entry $164.85 Now $165.31 +0.28% settles Dec 2
  8. Oct 30, 202617d ago 144 Neutral 1/10 Entry $145.35 Now $165.31 +13.73% settles Dec 1
  9. Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $146.10 Now $165.31 +13.15% settles Nov 30
  10. Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $145.53 Now $165.31 +13.59% settles Nov 25
Showing 10 of 30

US Market Status

Market Closed · Opens in 8h 30m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 28, 2026